Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 199

1.

The Long-term Oxygen Treatment Trial (LOTT) for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned.

Yusen RD, Criner GJ, Sternberg AL, Au DH, Fuhlbrigge AL, Albert RK, Casaburi R, Stoller JK, Harrington KF, Cooper JAD Jr, Diaz P, Gay S, Kanner R, MacIntyre N, Martinez FJ, Piantadosi S, Sciurba F, Shade D, Stibolt T, Tonascia J, Wise R, Bailey WC; LOTT Research Group.

Ann Am Thorac Soc. 2017 Oct 31. doi: 10.1513/AnnalsATS.201705-374SD. [Epub ahead of print]

PMID:
29087741
2.

The Relationships of Expectancies With E-cigarette Use Among Hospitalized Smokers: A Prospective Longitudinal Study.

Hendricks PS, Thorne CB, Lappan SN, Sweat NW, Cheong J, Ramachandran R, Kohler CL, Bailey WC, Harrington KF.

Nicotine Tob Res. 2017 Feb 11. doi: 10.1093/ntr/ntx043. [Epub ahead of print]

PMID:
28199715
3.

Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study.

Wells JM, Estepar RS, McDonald MN, Bhatt SP, Diaz AA, Bailey WC, Jacobson FL, Dransfield MT, Washko GR, Make BJ, Casaburi R, van Beek EJ, Hoffman EA, Sciurba FC, Crapo JD, Silverman EK, Hersh CP; COPDGene Investigators.

BMC Pulm Med. 2016 Dec 1;16(1):169.

4.

Withdrawal exposure with withdrawal regulation training for smoking cessation: a randomized controlled pilot trial.

Hendricks PS, Hall SM, Tyus LR, Thorne CB, Lappan SN, McMurray MV, Bailey WC, Cropsey KL, Baker TB.

Drug Alcohol Depend. 2016 Jul 1;164:28-37. doi: 10.1016/j.drugalcdep.2016.04.022. Epub 2016 Apr 26.

PMID:
27179823
5.

Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.

Stoller JK, Aboussouan LS, Kanner RE, Wilson LA, Diaz P, Wise R; LOTT Research Group.

Ann Am Thorac Soc. 2015 Dec;12(12):1796-804. doi: 10.1513/AnnalsATS.201506-389OC.

6.

β-Blockers are associated with a reduction in COPD exacerbations.

Bhatt SP, Wells JM, Kinney GL, Washko GR Jr, Budoff M, Kim YI, Bailey WC, Nath H, Hokanson JE, Silverman EK, Crapo J, Dransfield MT; COPDGene Investigators.

Thorax. 2016 Jan;71(1):8-14. doi: 10.1136/thoraxjnl-2015-207251. Epub 2015 Aug 17.

7.

A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.

Wells JM, Jackson PL, Viera L, Bhatt SP, Gautney J, Handley G, King RW, Xu X, Gaggar A, Bailey WC, Dransfield MT, Blalock JE.

Am J Respir Crit Care Med. 2015 Oct 15;192(8):934-42. doi: 10.1164/rccm.201503-0543OC.

8.

Clinical and Radiologic Disease in Smokers With Normal Spirometry.

Regan EA, Lynch DA, Curran-Everett D, Curtis JL, Austin JH, Grenier PA, Kauczor HU, Bailey WC, DeMeo DL, Casaburi RH, Friedman P, Van Beek EJ, Hokanson JE, Bowler RP, Beaty TH, Washko GR, Han MK, Kim V, Kim SS, Yagihashi K, Washington L, McEvoy CE, Tanner C, Mannino DM, Make BJ, Silverman EK, Crapo JD; Genetic Epidemiology of COPD (COPDGene) Investigators.

JAMA Intern Med. 2015 Sep;175(9):1539-49. doi: 10.1001/jamainternmed.2015.2735. Erratum in: JAMA Intern Med. 2015 Sep;175(9):1588.

9.

Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.

Smith LJ, Kalhan R, Wise RA, Sugar EA, Lima JJ, Irvin CG, Dozor AJ, Holbrook JT; American Lung Association Asthma Clinical Research Centers.

JAMA. 2015 May 26;313(20):2033-43. doi: 10.1001/jama.2015.5024.

10.

The Impact of Parent's Health Literacy on Pediatric Asthma Outcomes.

Harrington KF, Zhang B, Magruder T, Bailey WC, Gerald LB.

Pediatr Allergy Immunol Pulmonol. 2015 Mar 1;28(1):20-26.

11.

Differences in Electronic Cigarette Awareness, Use History, and Advertisement Exposure Between Black and White Hospitalized Cigarette Smokers.

Baumann AW, Kohler C, Kim YI, Cheong J, Hendricks P, Bailey WC, Harrington KF.

J Cancer Educ. 2015 Dec;30(4):648-54. doi: 10.1007/s13187-014-0767-y.

12.

Hospitalized smokers' expectancies for electronic cigarettes versus tobacco cigarettes.

Hendricks PS, Cases MG, Thorne CB, Cheong J, Harrington KF, Kohler CL, Bailey WC.

Addict Behav. 2015 Feb;41:106-11. doi: 10.1016/j.addbeh.2014.09.031. Epub 2014 Sep 28.

13.

Fourier transform microwave and millimeter-wave spectroscopy of bromoiodomethane, CH2BrI.

Bailleux S, Duflot D, Taniguchi K, Sakai S, Ozeki H, Okabayashi T, Bailey WC.

J Phys Chem A. 2014 Dec 18;118(50):11744-50. doi: 10.1021/jp510119e. Epub 2014 Dec 5.

PMID:
25420099
14.

NIH electronic cigarette workshop: developing a research agenda.

Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, Eissenberg TE, Fiore MC, Goniewicz ML, Haverkos L, Hecht SS, Henningfield JE, Hughes JR, Oncken CA, Postow L, Rose JE, Wanke KL, Yang L, Hatsukami DK.

Nicotine Tob Res. 2015 Feb;17(2):259-69. doi: 10.1093/ntr/ntu214. Epub 2014 Oct 21.

15.

Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational study.

Bhatt SP, Wells JM, Kim V, Criner GJ, Hersh CP, Hardin M, Bailey WC, Nath H, Kim YI, Foreman MG, Stinson DS, Wilson CG, Rennard SI, Silverman EK, Make BJ, Dransfield MT; COPDGene Investigators.

Lancet Respir Med. 2014 Nov;2(11):911-918. doi: 10.1016/S2213-2600(14)70185-7. Epub 2014 Sep 9.

16.

Obesity and symptoms of depression contribute independently to the poor asthma control of obesity.

Kapadia SG, Wei C, Bartlett SJ, Lang J, Wise RA, Dixon AE; American Lung Association Asthma Clinical Research Centers.

Respir Med. 2014 Aug;108(8):1100-7. doi: 10.1016/j.rmed.2014.05.012. Epub 2014 Jun 9.

17.

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.

Criner GJ, Connett JE, Aaron SD, Albert RK, Bailey WC, Casaburi R, Cooper JA Jr, Curtis JL, Dransfield MT, Han MK, Make B, Marchetti N, Martinez FJ, Niewoehner DE, Scanlon PD, Sciurba FC, Scharf SM, Sin DD, Voelker H, Washko GR, Woodruff PG, Lazarus SC; COPD Clinical Research Network; Canadian Institutes of Health Research.

N Engl J Med. 2014 Jun 5;370(23):2201-10. doi: 10.1056/NEJMoa1403086. Epub 2014 May 18.

18.

Electronic cigarette awareness, use history, and expected future use among hospitalized cigarette smokers.

Harrington KF, Hull NC, Akindoju O, Kim YI, Hendricks PS, Kohler C, Bailey WC.

Nicotine Tob Res. 2014 Nov;16(11):1512-7. doi: 10.1093/ntr/ntu054. Epub 2014 May 13.

19.

FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices.

Bhatt SP, Kim YI, Wells JM, Bailey WC, Ramsdell JW, Foreman MG, Jensen RL, Stinson DS, Wilson CG, Lynch DA, Make BJ, Dransfield MT.

Ann Am Thorac Soc. 2014 Mar;11(3):335-41. doi: 10.1513/AnnalsATS.201308-251OC.

20.

Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.

Woodruff PG, Chatila W, Connett JE, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Marchetti N, Rogers TJ, Scanlon PD, Sin DD, Voelker H, Wendt C, Albert RK; COPD Clinical Research Network.

Eur Respir J. 2014 Jan;43(1):295-8. doi: 10.1183/09031936.00140613. Epub 2013 Oct 17. No abstract available.

Supplemental Content

Loading ...
Support Center